Ramsay Health Care (AU:RHC)
ASX:RHC
Want to see AU:RHC full AI Analyst Report?
RHC Stock Chart & Stats
AU$41.21
-AU$0.38(-1.09%)
At close: 4:00 PM EST
AU$41.21
-AU$0.38(-1.09%)
Day’s Range― - ―
52-Week RangeAU$30.39 - AU$44.73
Previous CloseN/A
Volume335.68K
Average Volume (3M)804.76K
Market Cap
AU$8.53B
Enterprise ValueAU$25.91B
Total Cash (Recent Filing)AU$469.00M
Total Debt (Recent Filing)AU$17.53B
Price to Earnings (P/E)12.3
Beta1.13
Next Earnings
Aug 27, 2026EPS Estimate
0.66Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)1.18
Shares Outstanding230,829,800
10 Day Avg. Volume739,925
30 Day Avg. Volume804,756
Financial Highlights & Ratios
PEG Ratio-12.47
Price to Book (P/B)5.91
Price to Sales (P/S)1.67
P/FCF Ratio42.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$41.17Price Target Upside-0.09% Downside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.36
Revenue Forecast (FY)AU$18.94B
Bulls Say, Bears Say
Bulls Say
Australia Operating MomentumSustained organic growth in Australia — higher admissions, stronger private revenue and rising theatre utilisation — underpins reliable recurring cash flows. As the company’s largest market, continued margin improvement there supports group earnings resilience and funds reinvestment and shareholder returns over the medium term.
Improved Cash GenerationMaterial OCF improvement and stronger free‑cash‑flow trends enhance financial flexibility. Better cash conversion supports debt servicing, targeted capex, dividends and de‑risking initiatives, reducing refinancing pressure and enabling execution of multiyear transformation without overreliance on new external funding.
Capital Discipline & De‑riskingManagement is actively simplifying the group, cutting development CapEx and locking in cheaper debt, which lowers ongoing funding needs and execution risk. The proposed Sante demerger and disciplined capex signal structural capital allocation focus that can sustainably improve balance‑sheet optionality.
Bears Say
Elevated LeverageHigh group and Sante‑level leverage increase vulnerability to interest rates and refinancing cycles. Elevated debt restricts strategic flexibility, forces prioritisation of cash to servicing and deleveraging, and amplifies downside risk if regional operating shocks persist, delaying recovery timelines.
UK NHS Funding RiskDependence on public payor contracts in the UK exposes volumes and pricing to political and budget cycles. Prolonged NHS underfunding or delayed agreements can structurally depress utilisation and revenue, compressing margins in a material region and offsetting gains from private markets.
Elysium Turnaround ExecutionThe prolonged underperformance and asset rationalisation in Elysium signal structural demand and cost issues in that segment. Continued closures and higher operating costs weigh on margins and cash flow, requiring sustained execution risk and potentially multi‑period restructuring before returns normalize.
Ramsay Health Care News
RHC FAQ
What was Ramsay Health Care’s price range in the past 12 months?
Ramsay Health Care lowest share price was AU$30.39 and its highest was AU$44.73 in the past 12 months.
What is Ramsay Health Care’s market cap?
Ramsay Health Care’s market cap is AU$8.53B.
When is Ramsay Health Care’s upcoming earnings report date?
Ramsay Health Care’s upcoming earnings report date is Aug 27, 2026 which is in 98 days.
How were Ramsay Health Care’s earnings last quarter?
Ramsay Health Care released its earnings results on Feb 25, 2026. The company reported AU$0.71 earnings per share for the quarter, beating the consensus estimate of AU$0.597 by AU$0.113.
Is Ramsay Health Care overvalued?
According to Wall Street analysts Ramsay Health Care’s price is currently Overvalued.
Does Ramsay Health Care pay dividends?
Ramsay Health Care pays a Semiannually dividend of AU$0.4 which represents an annual dividend yield of 2.25%. See more information on Ramsay Health Care dividends here
What is Ramsay Health Care’s EPS estimate?
Ramsay Health Care’s EPS estimate is 0.66.
How many shares outstanding does Ramsay Health Care have?
Ramsay Health Care has 230,829,800 shares outstanding.
What happened to Ramsay Health Care’s price movement after its last earnings report?
Ramsay Health Care reported an EPS of AU$0.71 in its last earnings report, beating expectations of AU$0.597. Following the earnings report the stock price went up 10.348%.
Which hedge fund is a major shareholder of Ramsay Health Care?
Currently, no hedge funds are holding shares in AU:RHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ramsay Health Care Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$41.17 (-0.09% Downside)
AU$41.17 (-0.09% Downside)
Blogger Sentiment
Bullish
AU:RHC Sentiment 83%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$655.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.10%
12-Months-Change
Fundamentals
Return on Equity
5.75%
Trailing 12-Months
Asset Growth
13.13%
Trailing 12-Months
Company Description
Ramsay Health Care
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
RHC Company Deck
RHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Positive overall: the call emphasizes strong, broad-based underlying profit growth driven by Australia, improved cash flow, active capital-discipline measures, and material operational progress on the transformation agenda. These positives are tempered by clear and material regional challenges — notably UK NHS funding uncertainty, Elysium underperformance, French funding headwinds and elevated leverage in Ramsay Sante — which management is actively addressing through turnaround programs, refinancing and a proposed demerger. The balance of the narrative is constructive but cautious, with meaningful risks to monitor.View all AU:RHC earnings summariesRHC Stock 12 Month Forecast
Average Price Target
AU$41.17
▼(-0.09% Downside)
Technical Analysis
Healius Limited
―
Regis Healthcare Ltd.
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---